Learn more about whether Intra-Cellular Therapies, Inc. or Jazz Pharmaceuticals plc is a better investment based on AAII's A+ ...

Perhaps the Tuesday pharma sell-off was mitigated by indications Trump and his team might be amenable to either a softer or more gradual approach to industry tariffs. That bearishness about the ...

President Donald Trump's proposed tariffs could raise the cost of some cancer treatments by as much as $10,000, while also raising prices for cheaper everyday drugs, a new analysis has found.

The U.S. Food and Drug Administration said on Tuesday it had named Scott Steele as acting director of its Center for Biologics Evaluation and Research (CBER), following the exit of top vaccine ...

Learn more about whether Haleon plc or Jazz Pharmaceuticals plc is a better investment based on AAII's A+ Investor grades, ...

Bill would punish drug companies for raising prescription drug prices in the commercial market faster than the rate of ...

Drugmakers are pushing back against pharmaceutical tariffs. Some companies are lobbying the Trump administration to phase in ...

Significant layoffs across the FDA, CDC and NIH are ushering in a new era of public health under the Trump administration.

Experts warn about unlisted prescription drugs in "natural" performance enhancers that could trigger life-threatening ...

Major drugmakers tumble as Wall Street braces for new tariffs with potential implications for the pharma industry. Read more here.

Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...

BioReference Health, a biotech company, is laying off 81 employees at its main laboratory in Elmwood Park. The move comes ...